Vistagen Therapeutics Cash Flow Statement (2010-2025) | VTGN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-6.21M-7.75M-12.79M-10.53M-16.69M-19.78M-17.48M-9.76M-12.23M-6.90M-6.59M-6.35M-9.52M-10.73M-12.96M-14.09M-13.63M-15.10M-19.42M-18.90M
Share-based Compensation (Quarter)
0.49M0.59M0.76M0.72M1.40M0.96M1.03M0.75M0.60M0.57M0.58M0.51M0.52M1.16M1.11M1.08M0.96M0.92M1.10M1.10M
Gains from Investment Securities (Quarter)
200.00900.000.80M1.69M-0.00M0.61M1.22M-100.000.17M400.00-800.00-0.01M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
10.73M0.45M0.00M
Cash from Operations (Quarter)
-5.28M-6.17M-17.62M-12.05M-15.59M-15.97M-16.34M-9.93M-7.47M-7.89M-6.19M-4.75M-6.99M-10.87M-10.89M-10.28M-10.06M-18.80M-13.80M-17.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.09M0.09M0.19M0.27M0.09M0.10M0.10M0.10M0.10M0.11M0.11M0.11M0.11M0.12M0.12M0.12M0.13M0.13M0.13M0.14M
Depreciation & Amortization (CF) (Quarter)
0.04M0.03M0.04M0.04M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.04M0.04M0.04M0.04M0.05M0.05M
Change in Working Capital
Change in Receivables (Quarter)
0.04M-0.00M-0.04M0.00M
Change in Accured Expenses (Quarter)
1.12M2.07M3.69M-1.51M-0.49M2.01M-2.05M-1.46M0.58M-1.21M-0.45M0.27M1.92M-0.46M1.20M1.98M2.96M-2.42M3.20M0.29M
Investing Activities
Capital Expenditures (Quarter)
0.03M0.15M0.20M-100.00-0.20M0.18M0.02M-0.20M0.02M0.01M0.04M-0.04M0.10M-0.10M0.03M0.10M0.03M
Change in Acquisitions & Divestments (Quarter)
5.50M2.00M4.53M8.00M2.00M6.00M
Cash from Investing Activities (Quarter)
-0.03M-0.15M-0.20M100.00-100.00-0.18M-0.02M-0.01M-0.53M-0.03M-0.03M-5.47M-7.79M-0.42M0.53M-0.79M-0.09M0.10M
Financing Activities
Other financing activities (Quarter)
0.16M0.06M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
1.02M
Long-Term Debt Repayments (Quarter)
0.10M0.10M0.31M0.31M0.31M0.20M0.79M-0.00M0.09M0.27M0.28M
Change in Capital Stock
Shares Issued (Quarter)
4.90M0.04M4.00M1.95M-0.01M0.05M0.00M-0.06M1.15M35.10M0.00M93.45M0.09M1.10M-1.19M0.40M27.90M2.30M
Preferred Shares Issued (Quarter)
100.00
Misc.
Cash from Financing Activities (Quarter)
4.08M0.99M8.34M2.12M0.02M-0.01M-0.33M-0.30M-0.40M0.88M34.18M93.73M-0.38M0.09M1.17M1.95M1.49M27.65M2.11M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-1.22M-5.33M-9.48M-9.93M-15.56M-16.15M-16.70M-10.25M-8.40M-7.02M27.99M88.95M-7.39M-16.25M-18.67M-9.53M-7.58M-18.15M13.80M-15.41M
Free Cash Flow (Quarter)
-5.31M-6.32M-17.82M-12.05M-15.39M-16.14M-16.37M-9.73M-7.47M-7.89M-6.19M-4.76M-7.00M-10.91M-10.84M-10.38M-9.96M-18.83M-13.89M-17.66M
Net Cash Flow (Quarter)
-1.22M-5.33M-9.48M-9.93M-15.56M-16.15M-16.70M-10.25M-8.40M-7.02M27.99M88.95M-7.39M-16.25M-18.67M-9.53M-7.59M-18.10M13.76M-15.42M